Financial Statements — CLGN
Balance Sheet
(in millions USD)| Metric | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Cash & Equivalents | 18.92 | 22.28 | 36.29 | 17.49 |
| Accounts Receivable | 0.25 | 10.16 | 0.01 | 0.28 |
| Inventory | 0.44 | 1.55 | 1.36 | 0.94 |
| Total Current Assets | 20.34 | 34.86 | 38.27 | 49.77 |
| Property, Plant & Equipment | 2.56 | 2.93 | 2.93 | 2.12 |
| Intangible Assets | 0.16 | 0.22 | 0.24 | 0.16 |
| Total Non-current Assets | 6.23 | 6.71 | 6.14 | 5.25 |
| Total Assets | 26.57 | 41.57 | 44.41 | 55.02 |
| Total Current Liabilities | 3.24 | 2.78 | 2.36 | 2.93 |
| Total Non-current Liabilities | 2.60 | 2.75 | 2.55 | 2.65 |
| Total Liabilities | 5.84 | 5.53 | 4.91 | 5.58 |
| Retained Earnings | (105.15) | (87.67) | (80.94) | (65.95) |
| Total Stockholder Equity | 20.73 | 36.04 | 39.51 | 49.44 |
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Total Revenue | 0.25 | 10.18 | 0.07 | 0.69 |
| Cost of Revenue | 0.54 | 0.62 | 0.04 | 0.43 |
| Gross Profit | (0.29) | 9.57 | 0.02 | 0.26 |
| Research & Development | 2.70 | 2.57 | 2.60 | 1.90 |
| Selling, General & Admin | 1.42 | 1.32 | 1.61 | 1.42 |
| Total Operating Expenses | 4.12 | 3.89 | 4.21 | 3.33 |
| Operating Income | (4.41) | 5.68 | (4.18) | (3.06) |
| Net Income | (4.21) | 5.76 | (4.28) | (3.04) |
| Basic EPS | (0.37) | 0.51 | (0.39) | -- |
| Diluted EPS | (0.37) | 0.49 | (0.39) | -- |
Cash Flow Statement
(in millions USD)| Metric | Q2
2024 | Q2
2023 | Q2
2022 | Q2
2021 |
|---|
| Operating Cash Flow | (7.18) | (7.19) | -- | 7.74 |
| Capital Expenditures | 0.28 | 0.48 | 0.68 | 0.37 |
| Free Cash Flow* | (7.46) | (7.68) | -- | 7.37 |
| Investing Cash Flow | (0.34) | (0.54) | 29.55 | (30.45) |
| Financing Cash Flow | 0.01 | 0.89 | 1.47 | 36.87 |
* Derived from reported values
